SYM FINANCIAL Corp
Source: SEC Form 13F · as of Mar 2026SYM FINANCIAL Corp holds 24 biotech & pharma companies tracked by BioSniper, totaling $19.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
24
Total value held
$19.0M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 7,380 | $6.8M |
| JNJJOHNSON & JOHNSON | 8,803 | $2.2M |
| MRKMerck & Co., Inc. | 8,336 | $1.0M |
| BMYBRISTOL MYERS SQUIBB CO | 14,029 | $851K |
| ABBVAbbVie Inc. | 3,845 | $836K |
| GMOptec International, Inc. | 10,888 | $811K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,783 | $753K |
| NVSNovartis AG | 3,534 | $540K |
| INCYIncyte Corp. | 5,377 | $506K |
| GILDGILEAD SCIENCES, INC. | 3,550 | $495K |
| REGNREGENERON PHARMACEUTICALS, INC. | 595 | $460K |
| IDXXIDEXX LABORATORIES INC /DE | 777 | $437K |
| ABTABBOTT LABORATORIES | 3,897 | $400K |
| PMPhilip Morris International Inc | 2,103 | $348K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 6,088 | $336K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 16,170 | $299K |
| MOHMolina Healthcare Inc | 2,111 | $281K |
| PFEPFIZER INC | 9,424 | $265K |
| AMGNAMGEN INC | 743 | $261K |
| NBIXNEUROCRINE BIOSCIENCES INC | 1,942 | $256K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 4,235 | $239K |
| IQVIQVIA Holdings Inc. | 1,377 | $235K |
| MCKMcKesson Corporation | 253 | $219K |
| BIIBBIOGEN INC. | 1,150 | $211K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.